Natco Pharma inks pact with Hyderabad University

Natco Pharma has signed an MoU with the University of Hyderabad to carry out advance research in the areas of pharmaceutical segment.

As per the agreement, the focus areas would be discovery of novel drugs, development of drug delivery systems viz., nano formulations of new chemical entities and biotechnological processes for specific products with potential commercial importance.

Natco and the varsity will promote cooperation in academic exchange, R & D collaborations, training and research in the areas of biotechnology, pharmacology, toxicology, pharmaceutical technology, and organising of national and international symposia, conferences, specialized exhibitions etc.

The agreement was signed by Chowdary V Nannapaneni, Chairman and Managing Director of Natco Pharma Ltd. and P Sardar Singh, Registrar of UoH.

The School has been working with Natco Pharma and in one of the projects has resulted in developing one of the molecules to Phase-II clinical trials for the treatment of chronic myeloid leukaemia. It has a faculty of 55 with 350 PhD and 60 Post Docs and latest research facilities.

Research Desk

Next Post

Centre to sign contracts for 31 oil and gas fields

Thu Mar 23 , 2017
Next week, the central government will ink pacts for the 31 small discovered oil and gas fields it had auctioned in the first bid round in more than six years. According to a PTI report, state-owned oil firms IOC, BPCL and HPCL had cornered a third of the fields whose […]
Centre to sign contracts for 31 oil and gas fields


Blog Stats